Head and Neck Squamous Cell Carcinoma — Research

Head and Neck Squamous Cell Carcinoma — Research · CancerIndex

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

pubmedComputed3 windows · counts computed by CancerIndex from PubMed E-utilities; the exact query is stored with each count.

Window	Period	Records (count)	Exact query	Computed	Source
All time	… → 2026-09-11	15,841	`("Squamous Cell Carcinoma of Head and Neck"[mh] OR "Carcinoma, Squamous Cell of Head and Neck"[mh])`	2026-09-11	pubmed
Last 5 years	2021-01-01 → 2026-12-31	9,035	`("Squamous Cell Carcinoma of Head and Neck"[mh] OR "Carcinoma, Squamous Cell of Head and Neck"[mh]) AND (2021/01/01:2026/12/31[dp])`	2026-09-11	pubmed
Last 12 months	2025-09-11 → 2026-09-11	1,217	`("Squamous Cell Carcinoma of Head and Neck"[mh] OR "Carcinoma, Squamous Cell of Head and Neck"[mh]) AND (2025/09/11:2026/09/11[dp])`	2026-09-11	pubmed

Data updated 20 days agoSource updated unknownsource: pubmed E-utilities

Literature

Linked publications (48)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedPublishedShowing 26–48 of 48 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

p27 and BCL2 expression predicts response to chemotherapy in head and neck squamous cell carcinomas.
· Oral Oncol · 2014 · PMID 24239278 · validated civic_curation pubmed
Correlation of basic fibroblast growth factor expression with the invasion and the prognosis of oral squamous cell carcinoma.
· J Oral Pathol Med · 2006 · PMID 16454808 · validated civic_curation pubmed
Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trial.
· Lancet Oncol · 2015 · PMID 25892145 · validated civic_curation pubmed